Is Rigetti Computing Stock a Buy Right Now?

Rigetti has received up to $100 million in potential U.S. government funding over three years, a constructive long-term catalyst for the quantum computing developer. The company’s Q1 2026 revenue tripled year over year to $4.4 million, but operating losses remain wide and profitability is still distant. Shares are volatile, down over 4% in 2026 but up nearly 85% over the past 12 months, with analysts’ average price target at $29 versus about $21 currently.

Analysis

The state funding is less important as direct revenue than as validation that shifts the financing curve for the entire quantum stack. That matters because the binding constraint in this sector is not technical progress alone, but the market’s willingness to finance long-dated capex before any credible commercial workload exists. A government backstop can compress the probability-weighted funding discount for the next 12-24 months, which is why the strongest near-term beneficiary may be sentiment rather than fundamentals.

The bigger second-order effect is competitive: a subsidized player with access to a visible runway forces peers to keep spending into a race that still lacks a clear end-market. That can raise customer acquisition costs for pure plays like IONQ and pressure smaller private competitors, but it also increases the odds of industry consolidation if commercial use cases remain elusive through 2027-2029. Large incumbents like GOOGL and IBM are better positioned to win the eventual platform layer because they can absorb prolonged R&D burn without needing the stock to remain bid.

From a risk standpoint, the stock’s move will remain mostly sentiment-driven over the next several quarters, but any evidence that the funding comes with milestone-based constraints or procurement delays would deflate the multiple quickly. The asymmetry is that a true commercial breakthrough would re-rate the entire group, while failure merely shifts the market from enthusiasm to dilution concern. That makes this a classic “good headline, weak operating leverage” setup unless revenue starts to compound materially above the current research-contract pace.

The contrarian read is that the market may be underestimating how much of this can be monetized by the incumbents rather than the pure-play quantum names. The most durable winner is likely the company that owns adjacent enterprise distribution, cloud relationships, and hardware/software integration, not necessarily the one with the most aspirational technical narrative. In that sense, this is less a call on quantum computing’s future and more a call on which balance sheet survives long enough to own it.

Key Decisions for Investors

• Long IONQ / short RGTI as a 3-6 month relative-value trade: if government support keeps quantum sentiment elevated, the stronger commercial narrative should outperform the weaker one, while reducing single-name execution risk.
• Buy GOOGL or IBM on weakness over the next 1-3 months as a ‘picks-and-shovels’ hedge to the quantum theme: they have the balance sheets and customer channels to capture enterprise adoption if the market shifts from pure-play speculation to integration.
• Sell covered calls on RGTI against existing longs for the next 30-60 days: headline support can keep implied volatility elevated, allowing investors to monetize sentiment while capping upside in a name still far from fundamental proof.
• Use any 15-20% drawdown in RGTI over the next 6 months to fade momentum rather than add aggressively: absent a step-change in booked commercial revenue, the stock remains vulnerable to dilution, milestone slippage, and beta compression.
• For more aggressive accounts, consider a long-dated call spread in IONQ or a basket of IONQ/GOOGL/IBM rather than outright RGTI: this captures sector upside if quantum commercialization accelerates while avoiding the highest cash-burn and headline-risk profile.